Genenta Science

/Genenta Science

IPO

Genenta Science

Biotechnology

We are a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors.

Symbol

GNTA

Price Range
$10.50 - $12.50

Final Shares
2,608,695

Anticipated Date
December 15, 2021

Underwriters
ROTH CAPITAL PARTNERS, LLC

This offering is no longer available

To view the prospectus for Genenta Science IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange